ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Survival"

  • 2022 American Transplant Congress

    Steatosis Following Liver Transplantation for Nonalcoholic Steatohepatitis is Associated with a Higher Rate of Cardiovascular Complications

    W. Alhamoudi1, S. Alqahtani2, K. Bzeizi2, A. Albenmousa2, Y. Saleh2, D. Broering2, S. Alghamdi2

    1Medicine, King Saud University, Riyadh, Saudi Arabia, 2Liver Transplantation, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

    *Purpose: Cirrhosis secondary to Nonalcoholic Steatohepatitis (NASH) is projected to become the leading indication for liver transplantation (LT) worldwide. Objectives: to evaluate the prevalence of…
  • 2022 American Transplant Congress

    Area Deprivation Index is Associated with Worse Patient Survival Following Adult Liver Transplantation

    J. Hendele1, J. Perkins2, J. Nichols3, A. Dick1

    1Division of Transplant Surgery, Department of Surgery, University of Washington, Seattle, WA, 2Clinical and Bio-Analytics Transplant Laboratory (CBATL), University of Washington, Division of Transplant Surgery, Department of Surgery, Seattle, WA, 3School of Medicine, University of Washington, Seattle, WA

    *Purpose: Area Deprivation Index (ADI) has been utilized as a granular measure of local socioeconomic status for nearly two decades. This study is the first…
  • 2022 American Transplant Congress

    Characterizing Outcomes of Patients with Colorectal Liver Metastases (CRLM) Undergoing Liver Transplantation (LT) Evaluation

    E. Takoushian1, E. Brandon1, B. Samstein2, K. Halazun2

    1Liver Transplantation, New York Presbyterian Weill Cornell, New York, NY, 2Weill Cornell Medical Center, New York, NY

    *Purpose: LT is a novel therapy for patients with unresectable CRLM. 5 year survival using LT appears to be significantly better than systemic chemotherapy in…
  • 2022 American Transplant Congress

    Alemtuzumab and Basilximab Induction Therapy in Lung Transplantation

    M. Furukawa, E. Chan, P. G. Sanchez

    Cardiothoracic Surgery, UPMC, Pittsburgh, PA

    *Purpose: Induction therapy is used in about more than 80% of lung transplant centers and is increasing globally. Currently, there are no standards or guideline…
  • 2022 American Transplant Congress

    Adult-to-Adult Living Donor Liver Transplantation in Acute Liver Failure – Do Outcomes Justify the Risks?

    A. Shingina1, I. A. Ziogas2, P. Vutien3, E. Uleryk4, E. Renner5, M. P. Bhat6, J. Tinmouth4, J. Kim7

    1Vanderbilt University, Nashville, TN, 2Division of Hepatobiliary Surgery and Liver Transplantation, Vanderbilt University Medical Center, Nashville, TN, 3University of Washington Medical Center, Seattle, WA, 4University of Toronto, Toronto, ON, Canada, 5University of Manitoba, Saskatchewan, MB, Canada, 6Multi-Organ Transplant, UHN, Toronto, ON, Canada, 7Toronto General Hospital, Toronto, ON, Canada

    *Purpose: Living-donor Liver Transplantation(LDLT) has emerged as a safe and effective alternative in children and adults with pre-existing liver diseases. Utilization of LDLT for patients…
  • 2022 American Transplant Congress

    Retransplantation in a High-Volume Institution: Historical, Socioeconomic and Survival Trends

    D. von Ahrens, O. Sulimani, M. Holzner, M. Akhtar, S. Florman, A. Arvelakis

    The Mount Sinai Hospital, New York, NY

    *Purpose: Retransplantation for liver allograft failure is a challenge within the field. The evolution of organ allocation policy from Child to MELD in 2002 and…
  • 2022 American Transplant Congress

    Non-HLA Antibodies to G Protein-Coupled Receptors and Allograft Survival in Pediatric Kidney Transplant Recipients: Short- and Long-Term Outcomes

    M. Pearl1, L. Chen1, P. Weng1, E. T. Chambers2, E. F. Reed3

    1UCLA, Los Angeles, CA, 2Pediatrics, Duke University, Durham, NC, 3Univ of California LA, Los Angeles, CA

    *Purpose: We have recently shown that the non-HLA antibodies to angiotensin II type 1 receptor (AT1R-Ab) and endothelin-1 type A receptor (ETAR-Ab) are prevalent and…
  • 2022 American Transplant Congress

    Outcomes of Simultaneous Kidney Pancreas Transplantation in Patients with Type-1 and Type-2 Diabetes Mellitus

    H. Shokouh-Amiri1, M. S. Naseer2, S. Badar1, R. McMillan1, D. Aultman1, S. Tandukar1, N. Singh1, G. B. Zibari1

    1John C. McDonald Regional Transplant Center - Willis Knighton Health System, Shreveport, LA, 2Transplant, John C. McDonald Regional Transplant Center - Willis Knighton Health System, Shreveport, LA

    *Purpose: Advantages for type-2 diabetes mellitus (T2DM) patients receiving simultaneous kidney-pancreas transplantation (SKPT) as compared to kidney transplantation are shorter waiting times and availability of…
  • 2022 American Transplant Congress

    Effect of Anti Thymocyte Globulin Induction Therapy in Kidney Transplantation Network Meta-Analysis Using Recent Data

    S. Hwang, J. Song, K. Kim, S. Lee

    Inha University, Incheon, Korea, Republic of

    *Purpose: The use of induction immunosuppressant agents in transplantation is important factors in preserving graft kidney function to prevent rejection. However the question of which…
  • 2022 American Transplant Congress

    Telemedical Surveillance and Optimized Treatment of Blood Pressure in Kidney Transplant Recipients

    W. Düttmann1, M. G. Naik1, B. Zukunft1, B. Osmanodja1, G. Eleftheriadis1, S. Ronicke2, M. Choi1, F. Bachmann1, F. Halleck1, K. Budde1

    1Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Berlin, Germany, 2Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Berlin, Germany

    *Purpose: Patients with chronic kidney disease suffer often from cardiovascular diseases, especially high blood pressure and its complications such as stroke and heart attack. After…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 66
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences